Lung cancer in non-smokers a separate disease
October 10, 2008 — NEW YORK (Reuters Health) - Japanese investigators say that survival rates are better for patients with non-small cell lung cancer (NSCLC) who never smoked than in NSCLC patients with a history of smoking. Other disease characteristics are different as well between the two populations.
Drug combo doesn't boost lung cancer survival
October 6, 2008 — ZURICH/LONDON (Reuters) - Roche Holding AG and Genentech Inc said on Monday a study of the benefits of combining their Tarceva and Avastin drugs for lung cancer patients did not show an increase in overall survival.
Lilly's Alimta OK'd as front-line lung cancer drug
September 29, 2008 — BOSTON (Reuters) - Eli Lilly and Co on Monday said it has won U.S. approval for its drug Alimta as a first-line treatment for patients with advanced lung cancer.
Select news items provided by Reuters Health